invasion within the gastric wall, in 752 patients with gastric cancer treated with curative resection at the Department of Gastroenterological Surgery, Osaka University Hospital. The peritoneum was the most frequent site of recurrence in patients with gastric cancer who received curative resection (34.3%). Furthermore, the frequency increased with increased depth of invasion of the gastric wall (subserosal invasion, 34.9%; serosal invasion, 46.7%; and invasion of adjacent organs, 60.0%).At present, cytological examination of peritoneal lavage fl uid collected at laparotomy is performed to predict peritoneal spread [3][4][5], and this procedure has been incorporated in the Japanese staging system for gastric cancer [6]. The majority of patients with positive cytology on peritoneal lavage develop peritoneal metastasis, although the latter also occurs in patients with negative cytological results [3][4][5]. These results indicate that the conventional cytological examination lacks sensitivity for the detection of residual cancer cells and prediction of peritoneal spread.Molecular diagnosis using reverse transcriptasepolymerase chain reaction (RT-PCR) analysis has been used recently for the detection of cancer micrometastases [7][8][9]. RT-PCR is more sensitive than conventional cytological examination [10][11][12]. Based on several studies, the results of RT-PCR of peritoneal lavage fl uid correlate strongly with peritoneal recurrence and prognosis after curative surgery in patients with advanced gastric cancer [10,[12][13][14][15][16][17].In this article, we review the present status and future perspectives of molecular analysis of peritoneal lavage in patients with gastric cancer. We also describe our preliminary results and their possible clinical application.
AbstractThe purpose of this review is to examine the current status and future perspectives of the molecular analysis of peritoneal lavage fl uid in patients with gastric cancer. During the past 10 years, the polymerase chain reaction (PCR) has been applied for the molecular detection of free cancer cells in the ab dominal cavity of patients with gastric cancer, and its clinical signifi cance in establishing the presence of peritoneal dissemination has been assessed by several groups especially in Japan. The majority of these studies have confi rmed the predictive value of the molecular detection of peritoneal metastasis and recurrence using peritoneal lavage fl uid. Based on these fi ndings, since April 2006, the genetic diagnosis of body fl uids has been included in the Japanese Government public health insurance program for patients with solid tumors. However, there are still many obstacles to overcome before the genetic diagnosis of micrometastasis can be considered a routine laboratory assay. Here we review the importance of the molecular detection of cancer cells in the abdominal cavity, and the molecular techniques used for such diagnosis; we also provide some clinical examples to illustrate the value of molecular diagnosis.